Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Merck Sharp & Dohme Limited
Hertford Road, Hoddesdon, Hertfordshire, EN11 9BU
Telephone: +44 (0)1992 467 272
Fax: +44 (0)1992 479 292
Medical Information e-mail: medicalinformationuk@merck.com

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Summary of Product Characteristics last updated on the eMC: 26/10/2004
SPC OncoTICE

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 26/10/2004 and displayed until Current
Reasons for adding or updating:
  • Change to section 4.2 - Posology and Method of Administration
Updated on 28/07/2004 and displayed until 26/10/2004
Reasons for adding or updating:
  • Change to section 5.1 - Pharmacodynamic Properties
Updated on 28/07/2004 and displayed until 28/07/2004
Reasons for adding or updating:
  • Change to section 4.2 - Posology and Method of Administration
  • Change to section 4.3 - Contra-indications
  • Change to section 4.4 - Special Warnings and Precautions for Use
  • Change to section 4.8 - Undesirable Effects
  • Change to section 5.1 - Pharmacodynamic Properties
Updated on 28/08/2002 and displayed until 28/07/2004
Reasons for adding or updating:
  • Change to section 4.4 - Special Warnings and Precautions for Use
Updated on 03/08/2001 and displayed until 28/08/2002
Reasons for adding or updating:
  • Change to section 7 - Marketing Authorisation Holder
Updated on 06/09/1999 and displayed until 03/08/2001
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
  tice bcg